Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Agilent Technologies Thrives From the Forever Chemicals Crackdown

Agilent Technologies signage at its headquarters in Santa Clara, California, USA - June 9, 2023, an American company that provides instruments, software, services for laboratories — Stock Editorial Photography

Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics, and applied chemical markets. The company provides equipment systems, instruments, software and services that enable researchers and scientists to make breakthroughs in the medical sector and various fields. While its many segments are experiencing pullbacks in the end market, its top growth segment is being driven by solutions to address polyfluoroalkyl substances (PFAS), otherwise known as forever chemicals.

PFAS are called forever chemicals due to their extremely slow process of breaking down, if at all. They can accumulate in the human body and lead to health problems ranging from cholesterol, obesity, and cancer to developmental and reproductive issues. Agilent, through its Environmental and Forensics business, provides equipment and testing tools that help extract and screen for PFAS in water. 

Agilent Technologies competes with scientific instruments leader Thermo Fisher Scientific Inc. (NYSE: TMO), Danaher Co. (NYSE: DHR), and chromatography leader Waters Co. (NYSE: WAT).

Growing Awareness and Scrutiny Over Forever Chemicals

PFAS are man-made chemicals that have been used in consumer and industrial products since the 1940s. They are well known for their heat, stain, oil, and water-resistant properties. However, they have been gaining increased scrutiny for environmental and health risks.

PFAS is found in everyday products like water-proof clothing, non-stick pans, batteries, stain-resistant carpets, fast food containers, grease-resistant paper, candy wrappers, shampoo, nail polish, and even bottled water. A study found that 39 out of 101 bottled water products contained more PFAS than purified ones. PFAS was also found in 9 out of 11 plastic food storage bags.

Government Legislation Is Just Starting

The Biden-Harris Administration has been active in combating PFAS pollution. On April 10, 2024, they finalized the first-ever national drinking water standard, which aims to protect 100 million people from PFAS pollution. The Environmental Protection Agency (EPA) provided $1 billion in funding to implement PFAS testing and treatment in the nation’s public water systems.

This falls right into Agilent's wheelhouse. The company saw its Environmental and Forensics business revenue grow 4% YoY, driven by a rise in PFAS testing workflows in Europe and China. Potential Federal Drug Administration (FDA) regulations pertaining to PFAS-free product requirements would be a major catalyst for Agilent. While Agilent provides testing mainly for water, its addressable market would continue to expand into the food industry.

Agilent's Segments Are Slowing

Agilent reported fiscal Q3 2024 EPS of $1.32, beating consensus estimates by 6 cents. GAAP net income surged 155% YoY to $282 million. Non-GAAP net income fell 8% YoY to $385 million. Revenues slumped 5.6% YoY to $1.58 billion, still beating consensus estimates of $1.56 billion.

Life Sciences and Applied Markets Group (LSAG) had an 8% revenue decline to $782 million and an operating margin of 28.4%. The Agilent CrossLab Group (CG) saw a 4% spike to $411 million and a 34% operating margin. The Diagnostic and Genomics Group (DGG) saw a 9% revenue drop to $385 million and an operating margin of 18.3%.

Agilent Technologies CEO Padrig McDonnell commented, “While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated. We continue to make investments in our most promising growth opportunities. And we are mobilizing the organization to accelerate value creation through strategic transformation initiatives, which will drive margin expansion and growth—and increase our execution capabilities.”

Agilent Stock Is in an Ascending Triangle Pattern, Trying to Fill the Gap

An ascending triangle is comprised of a flat-top upper trendline, which is the resistance. The ascending trendline formed at $124.16, connecting the higher lows to meet at the apex point.

Agilent A stock chart

The gap formed on its previous earning report when shares fell from $144.75 to $135.18 was filled on its Q3 2024 earnings spike through $144.75, which pulled back to the ascending trendline where it bounced. Shares are slowly rising towards the flat-top upper trendline. The relative strength index (RSI) continues to rise slowly through the 63-band. Fibonacci (fib) pullback support levels are at $136.37, $131.77, $127.82 and $121.19.

Agilent Technologies stock has an average consensus price target of $141.60, and its highest analyst price target is $165.00.

Bullish investors can consider using cash-secured puts to take positions on pullbacks at the fib support levels. wheel strategy can be implemented to generate income upon being assigned shares and writing covered calls while collecting the 0.66% annual dividend yield.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.